Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALNY

Alnylam

$127.73

-4.23 (-3.21%)

, SNY

Sanofi

$44.67

0.77 (1.75%)

20:02
01/07/18
01/07
20:02
01/07/18
20:02
Recommendations
Alnylam, Sanofi analyst commentary at Piper Jaffray »

Deal with Sanofi…

ALNY

Alnylam

$127.73

-4.23 (-3.21%)

SNY

Sanofi

$44.67

0.77 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 18

    Jan

  • 16

    Feb

  • 25

    Mar

  • 02

    May

ALNY

Alnylam

$127.73

-4.23 (-3.21%)

17:10
01/07/18
01/07
17:10
01/07/18
17:10
Earnings
Alnylam expects to end 2017 with greater than $1.7B in cash »

The company now expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

ALNY

Alnylam

$127.73

-4.23 (-3.21%)

, SNY

Sanofi

$44.67

0.77 (1.75%)

17:10
01/07/18
01/07
17:10
01/07/18
17:10
Hot Stocks
Alnylam expects Patisiran to be first commercially available RNAi in mid-2018 »

Alnylam (ALNY) announced…

ALNY

Alnylam

$127.73

-4.23 (-3.21%)

SNY

Sanofi

$44.67

0.77 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 18

    Jan

  • 16

    Feb

  • 25

    Mar

  • 02

    May

ALNY

Alnylam

$127.73

-4.23 (-3.21%)

, SNY

Sanofi

$44.67

0.77 (1.75%)

17:03
01/07/18
01/07
17:03
01/07/18
17:03
Hot Stocks
Alnylam, Sanofi announce strategic restructuring of RNAi therapeutics alliance »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$127.73

-4.23 (-3.21%)

SNY

Sanofi

$44.67

0.77 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 18

    Jan

  • 16

    Feb

  • 25

    Mar

  • 02

    May

LLY

Eli Lilly

$85.14

0.46 (0.54%)

, ALNY

Alnylam

$134.65

2.8 (2.12%)

04:55
01/04/18
01/04
04:55
01/04/18
04:55
Conference/Events
Goldman Sachs to hold a conference »

Healthcare CEOs…

LLY

Eli Lilly

$85.14

0.46 (0.54%)

ALNY

Alnylam

$134.65

2.8 (2.12%)

BSX

Boston Scientific

$25.56

0.28 (1.11%)

ABBV

AbbVie

$99.95

1.54 (1.56%)

ALXN

Alexion

$124.95

0.9 (0.73%)

A

Agilent

$69.32

1.72 (2.54%)

BLUE

bluebird bio

$179.75

-2.15 (-1.18%)

MYL

Mylan

$43.14

0.03 (0.07%)

HUM

Humana

$251.28

-0.36 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

  • 10

    Jan

  • 18

    Jan

  • 31

    Jan

  • 01

    Feb

  • 16

    Feb

  • 26

    Feb

LLY

Eli Lilly

$84.68

-0.02 (-0.02%)

, ALNY

Alnylam

$131.85

4.8 (3.78%)

08:21
01/03/18
01/03
08:21
01/03/18
08:21
Conference/Events
Goldman Sachs to hold a conference »

Healthcare CEOs…

LLY

Eli Lilly

$84.68

-0.02 (-0.02%)

ALNY

Alnylam

$131.85

4.8 (3.78%)

BSX

Boston Scientific

$25.28

0.425 (1.71%)

ABBV

AbbVie

$98.41

1.41 (1.45%)

ALXN

Alexion

$124.05

4.46 (3.73%)

A

Agilent

$67.60

0.61 (0.91%)

BLUE

bluebird bio

$181.90

3.8 (2.13%)

MYL

Mylan

$43.11

0.8 (1.89%)

HUM

Humana

$251.64

3.03 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jan

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

  • 10

    Jan

  • 18

    Jan

  • 31

    Jan

  • 16

    Feb

  • 26

    Feb

CELG

Celgene

$104.46

-2.51 (-2.35%)

, BIIB

Biogen

$320.07

0.29 (0.09%)

10:27
12/28/17
12/28
10:27
12/28/17
10:27
Hot Stocks
Before the Move: Ten biotech names to watch in January »

In a research note to…

CELG

Celgene

$104.46

-2.51 (-2.35%)

BIIB

Biogen

$320.07

0.29 (0.09%)

VRTX

Vertex

$151.55

0.95 (0.63%)

ALNY

Alnylam

$128.56

3.88 (3.11%)

SNY

Sanofi

$43.16

0.05 (0.12%)

AVXS

AveXis

$110.99

-0.57 (-0.51%)

ICPT

Intercept

$62.96

-1.89 (-2.91%)

ASMB

Assembly Biosciences

$45.03

0.1 (0.22%)

AXON

Axovant Sciences

$5.30

-0.03 (-0.56%)

ACOR

Acorda Therapeutics

$22.40

0.2 (0.90%)

FGEN

FibroGen

$47.95

0.15 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jan

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

  • 02

    May

Over a month ago
ALNY

Alnylam

$125.59

1.93 (1.56%)

, SNY

Sanofi

$43.17

0.08 (0.19%)

07:08
12/18/17
12/18
07:08
12/18/17
07:08
Hot Stocks
Alnylam, Sanofi Genzyme submit MAA to EMA for Patisiran »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$125.59

1.93 (1.56%)

SNY

Sanofi

$43.17

0.08 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

  • 02

    May

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

12:59
12/15/17
12/15
12:59
12/15/17
12:59
Recommendations
Alnylam analyst commentary at Piper Jaffray »

Piper stays Overweight on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.71

2.38 (5.37%)

, UA

Under Armour; also tag UAA

$13.52

1.0749 (8.63%)

10:22
12/15/17
12/15
10:22
12/15/17
10:22
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

FL

Foot Locker

$46.71

2.38 (5.37%)

UA

Under Armour; also tag UAA

$13.52

1.0749 (8.63%)

UAA

Under Armour; also tag UA

$14.97

1.15 (8.32%)

CRTO

Criteo

$24.42

-7.19 (-22.75%)

SKX

Skechers

$38.07

1.15 (3.11%)

BMRN

BioMarin

$88.53

-0.13 (-0.15%)

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.